Imago Raises $80m Series C To Take Bomedemstat Into Phase III

Company Plans IPO In 2021 To Fund Additional Pivotal Trials

 
• By Mandy Jackson
  
Venture Capital Concept on the Mechanism of Metal Gears.
Imago closed an $80m series C with plans to launch an IPO in 2021 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business